CRC Research Update — July 13, 2026
Today's colorectal cancer research highlights
stage-i-ii
A collection of 45 issues
Liquid Biopsy Platform Now Detects Early-Stage Disease
Skip to content
The CRC Digest
Liquid Biopsy Platform Now Detects Early-Stage Disease
Plasmonic technology expanded to early-stage colorectal cancer. (EurekAlert)
This content is informational only and does not constitute medical advice.
Always consult your oncologist or care team.
© 2026 The CRC Digest —
crcdigest.com
CRC Research Update — July 12, 2026
Today's colorectal cancer research highlights
This Week in CRC Research — July 12, 2026
Weekly colorectal cancer research intelligence
CRC Research Update — July 03, 2026
Today's colorectal cancer research highlights
CRC Research Update — July 02, 2026
Today's colorectal cancer research highlights
CRC Research Update — June 27, 2026
Today's colorectal cancer research highlights
One-year surveillance colonoscopy after curative resection evaluated for diagnostic yield
Skip to content
The CRC Digest
One-year surveillance colonoscopy after curative resection evaluated for diagnostic yield
A retrospective study examined real-world outcomes of routine colonoscopy 1 year after colorectal cancer resection, despite limited evidence supporting its diagnostic yield. (Int J Colorectal Dis)
This content is informational only and does not
CRC Research Update — June 18, 2026
Today's colorectal cancer research highlights
Ultra-high TMB POLE-mutated stage II CRC patient develops severe renal toxicity after adjuvant immunotherapy
Skip to content
The CRC Digest
Ultra-high TMB POLE-mutated stage II CRC patient develops severe renal toxicity after adjuvant immunotherapy
A 28-year-old with stage IIB POLE-mutated MSS CRC whose TMB reached 717 mutations/Mb developed severe renal toxicity after off-label adjuvant envafolimab, raising questions about the safety of ICIs in